ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ ASX Shares
The blue chip ASX shares to buy in August
⏸️ Shares to Watch
Does the second wave of COVID-19 make these ASX 200 healthcare shares a buy?
Growth Shares
3 fantastic ASX growth shares to buy in August
Growth Shares
Get rich with these stellar ASX growth shares
Healthcare Shares
2 five star ASX healthcare shares to buy in July
⏸️ Investing
ResMed share price rockets to record highs
Growth Shares
My top 5 ASX growth shares to buy in FY 2021
Growth Shares
Want to beat the market? Try these 3 ASX growth shares
⏸️ ASX Shares
Invest like Warren Buffett and buy and hold these excellent ASX shares
Growth Shares
4 excellent ASX growth shares to buy in FY 2021
Share Market News
Which ASX shares will benefit from the second lockdown?
Share Market News
Nanosonics and 1 more ASX healthcare share to buy and hold beyond 2025
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
